Stemline Targeting cancer at its root
developing novel drugs that attack Cancer Stem Cells

DEF 14A

SEC Filing Details

Document Details

Filing Date
Apr 30, 2018
Document Date
Jun 21, 2018
Form Description
Official notification to shareholders of matters to be brought to a vote ("Proxy")
Filing Group
Proxy Filings
Company
Stemline Therapeutics
Issuer
STEMLINE THERAPEUTICS INC


Copyright 2018 - Stemline Therapeutics, Inc. All rights reserved